|
三生制葯, 01530.HK - 財務比率 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
2014-12 |
2013-12 |
2012-12 |
變現能力分析 |
流動比率(倍) |
2.47 |
5.44 |
5.49 |
4.6 |
2.85 |
2.68 |
2.4 |
1.96 |
3.58 |
0.75 |
10.34 |
13.2 |
速動比率(倍) |
2.26 |
5.04 |
5.0 |
4.18 |
2.52 |
2.45 |
2.23 |
1.73 |
3.4 |
0.67 |
9.95 |
12.78 |
償債能力分析 |
長期債項/股東權益(%) |
19.36 |
31.58 |
20.19 |
23.83 |
24.12 |
31.63 |
44.87 |
38.95 |
0.0 |
0.0 |
0.0 |
0.0 |
總債項/股東權益(%) |
34.47 |
34.47 |
21.5 |
27.26 |
29.21 |
38.25 |
59.57 |
46.9 |
7.2 |
66.22 |
0.0 |
0.0 |
總債項/資本運用(%) |
24.31 |
22.13 |
14.78 |
17.96 |
21.3 |
27.04 |
38.12 |
30.92 |
6.91 |
58.55 |
0.0 |
0.0 |
投資回報分析 |
股東權益回報率(%) |
11.04 |
14.77 |
13.5 |
7.82 |
10.12 |
14.83 |
12.65 |
10.92 |
9.36 |
31.29 |
8.96 |
7.43 |
資本運用回報率(%) |
7.79 |
9.48 |
9.28 |
5.15 |
7.38 |
10.48 |
8.09 |
7.2 |
8.98 |
27.66 |
8.13 |
7.3 |
總資產回報率(%) |
6.56 |
8.71 |
8.59 |
4.73 |
6.58 |
9.23 |
6.8 |
6.46 |
7.94 |
12.65 |
7.56 |
6.89 |
盈利能力分析 |
經營利潤率(%) |
25.71 |
33.61 |
29.81 |
18.06 |
23.3 |
32.81 |
29.9 |
30.82 |
34.91 |
31.97 |
24.36 |
19.9 |
稅前利潤率(%) |
25.31 |
33.15 |
29.28 |
17.52 |
23.0 |
32.63 |
29.51 |
30.39 |
35.14 |
31.85 |
23.84 |
19.87 |
邊際利潤率(%) |
19.82 |
27.92 |
25.87 |
14.96 |
18.31 |
27.86 |
25.05 |
25.47 |
31.45 |
25.8 |
10.95 |
15.49 |
營運能力分析 |
存貨周轉率(倍) |
10.05 |
9.63 |
9.24 |
9.02 |
10.06 |
11.92 |
9.92 |
10.66 |
12.45 |
11.26 |
24.71 |
18.52 |
投資收益分析 |
派息比率(%) |
35.63 |
11.36 |
25.13 |
0.0 |
0.0 |
0.0 |
15.44 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
相關統計 |
財政年度周最高價 |
9.1 |
8.61 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度周最低價 |
6.05 |
4.72 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最高市盈率(倍) |
12.97 |
9.79 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最低市盈率(倍) |
8.62 |
5.36 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最高週息率(%) |
4.13 |
2.12 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
財政年度最低週息率(%) |
2.75 |
1.16 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
|